** Shares of Australia's LTR Pharma LTP.AX rise as much as 17.2% to A$0.58, their biggest intraday pct gain since June 18

** Stock at its highest level since July 3

** LTP set to clock its second consecutive session of gains, if trend holds

** Stock up 1.9% in the week so far

** The clinical-stage biopharma firm signs a commercial agreement executed with Shed, a U.S. direct-to-consumer (DTC) telehealth platform

** Near 547,114 shares change hands, 1.0x the 30-day average volume

** Stock has fallen 27.1% this year, including session moves